Drill Rhume

Quick links to important sections

Drill Rhume

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Drill Rhume

Property Description
Active Ingredients Acetaminophen, Chlorphenamine
Form Oral preparation (Tablet)
Pharmacological Class Analgesic, Antipyretic, Antihistamine
General Purpose Symptomatic treatment of cold/rhinitis
Origin Synthetic

What Type of Medicine is Drill Rhume?

Drill Rhume is a proprietary medicine defined as a multicomponent formulation that belongs to a combined pharmacological class of Analgesics, Antipyretics, and Antihistamines (H1 receptor antagonists). This combination is designed for systemic delivery as an oral preparation in tablet form. This structure, which merges distinct therapeutic actions, is clinically recognized for its role in simultaneously addressing multiple acute cold symptoms, as fixed-dose combinations are designed to target several symptoms with a single administration.


Composition and General Purpose

The formula utilizes two distinct synthetic active ingredients: Acetaminophen (Paracetamol) and Chlorphenamine maleate (Chlorpheniramine). Acetaminophen, an N-acetyl-p-aminophenol derivative, provides the pain relief and temperature reduction components. The second compound, Chlorphenamine maleate, an alkylamine H1 receptor antagonist, works to reduce symptoms mediated by histamine. Antihistamines like Chlorphenamine are used for easing upper respiratory symptoms such as sneezing and runny nose associated with the common cold. The overall purpose of this dual-action is to provide comprehensive symptomatic treatment, which is utilized when experiencing general discomfort, fever, headache, and persistent runny nose concurrently.

Regulatory References

  1. European Medicines Agency (EMA)

What side effects are possible with Drill Rhume?

Possible side effects and safety information

The officially documented safety profile for Drill Rhume (Acetaminophen/Chlorphenamine) is determined by the regulatory classifications of its active components, defining effects across several body systems and frequency tiers.

Commonly Classified Adverse Reactions

Adverse reactions classified as Very Common or Common in regulatory documents often relate to the antihistamine component. Very Common reactions include drowsiness (somnolence) and sedation. Reactions classified as Common include dizziness, dry mouth, nausea, fatigue, and disturbance in attention.

System-Organ Classifications and Serious Reactions

Side effects are grouped by body system, including the Nervous System (e.g., confusion, abnormal coordination) and the Gastrointestinal System (e.g., constipation). The most significant safety concerns listed in regulatory sources involve the potential for Severe Hepatotoxicity (liver damage) associated with Acetaminophen, Severe Skin Reactions (such as Stevens-Johnson Syndrome), and rare Anaphylactic Reactions.

Population-Specific Safety Notes

Official labeling addresses specific population risks. Older adults are noted to have increased susceptibility to anticholinergic effects, such as dizziness and confusion. Children may paradoxically exhibit excitation or restlessness rather than sedation. Patients with underlying hepatic impairment face an increased risk of severe liver damage. Regulatory texts also advise caution regarding use during pregnancy (particularly the third trimester) and lactation.

Safety Restrictions

The label mandates that the medication should be avoided in conditions such as severe hepatic impairment, certain types of glaucoma, and states involving urinary retention. Use is restricted with other products containing Acetaminophen or other Antihistamines to prevent overdose and excessive CNS depression.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information

The officially documented overdose profile for Drill Rhume is characterized by two distinct, severe toxicological risks, classifying the event as a life-threatening scenario in regulatory documents.

Aspect Official Regulatory Statement
Documented Presentations Early, non-specific signs may include nausea, vomiting, diaphoresis, and malaise. Delayed, severe manifestations include abdominal pain and jaundice. Immediate CNS effects can present as profound sedation, dizziness, psychomotor agitation, seizures, and blurred vision.
Severe Outcomes The potential exists for fulminant liver necrosis, leading to hepatic failure and metabolic acidosis. Severe CNS depression, cardiorespiratory arrest, and renal tubular necrosis are also documented outcomes.
Urgent Action Required Seek emergency medical attention immediately or contact poison control right away. This immediate action is explicitly mandated by regulators, even when initial symptoms are absent, due to the high potential for delayed, life-threatening liver damage.
Antidote / Treatment The specific antidote, N-acetylcysteine (NAC), is required for the Acetaminophen component and must be administered rapidly. Supportive measures and hospital monitoring of liver function (e.g., enzyme assessment) are also explicitly required.
Specific Risk Notes Overdose risk is associated with exceeding the maximum daily limit. The risk of severe hepatotoxicity is documented as being elevated in patients with underlying hepatic impairment or heavy alcohol consumption.

Connection to the Overall Overdose Profile:

Regulatory documents define the overdose profile by two principal, severe toxicological risks: Acetaminophen-induced hepatic necrosis and Chlorphenamine-induced CNS collapse. This dual, potentially fatal presentation requires the explicit, regulator-mandated action to seek immediate medical attention for any suspected overdose exposure. This urgency is based on the necessity for timely administration of the specific antidote to prevent irreversible liver damage.

Therapeutic Uses of Drill Rhume

What Drill Rhume Treats — Main Uses and Benefits

The medication is used in areas where short-term symptom management is appropriate, applied in clinical settings that involve acute or unstable symptom patterns. It is relevant in contexts marked by increased discomfort or tension, and it is commonly used to help with multiple symptoms occurring together, as is typical of colds. The use is relevant for managing symptoms that interfere with daily comfort.

It is commonly used across conditions presenting with acute episodes such as cold or flu-like states, and helps address symptom clusters that may become intense. The medication is relevant for easing symptoms related to systemic imbalance, including fever and general body aches, and symptoms related to inflammatory or irritative processes in the nose, such as runny nose and sneezing.

The core benefit is that it provides support that helps ease the overall symptom burden during periods of heightened discomfort.

“The symptomatic relief contributes to improved day-to-day comfort, assisting with maintaining functional stability.”

Symptom Focus: Relief for Multi-Symptom Discomfort

Regulatory References

  1. NIH MedlinePlus overview on Chlorpheniramine

Eligibility and Restrictions for Use

The official regulatory profile for Drill Rhume (Acetaminophen and Chlorphenamine) defines eligibility based on age, pre-existing conditions, and physiological state.

Eligibility Scope

Populations for whom use is allowed (as stated in label): Adults and children 12 years of age and over. Use is generally permitted for children 6 to under 12 years under specified limitations.

Populations for whom use is contraindicated:

  • Patients with documented hypersensitivity to Acetaminophen, Chlorphenamine, or any product excipients.
  • Patients who have taken a Monoamine Oxidase Inhibitor (MAOI) within the last fourteen days.
  • Patients with severe hepatic impairment or severe active liver disease.
  • Patients with narrow-angle glaucoma or conditions causing bladder-neck obstruction or urinary retention.
  • Concurrent use with any other medicine containing acetaminophen.

Condition-Specific Eligibility Rules

Eligibility Status Applicable Conditions (Official Regulatory Caution)
Not Recommended Children under 6 years of age. Use in children under 4 years is often prohibited.
Restricted Use Pregnancy and Lactation (unless deemed essential by a physician).
Caution Advised Older adults, patients with mild to moderate hepatic or renal impairment, COPD, severe hypertension, or epilepsy.

Individuals who consume three or more alcoholic drinks daily are advised against use due to increased risk of hepatotoxicity.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns for the components of Drill Rhume (Acetaminophen and Chlorphenamine maleate) as defined by government regulatory authorities.


Official Interaction Statements

  • Contraindicated Combinations: Co-administration is strictly prohibited with any other medicine containing Acetaminophen (Paracetamol) to avoid exceeding the maximum daily dose and to mitigate the risk of severe liver damage. The use of Monoamine Oxidase Inhibitors (MAOIs) is also strictly contraindicated, requiring a separation interval of at least 14 days after stopping MAOI therapy.

  • Pharmacodynamic Reinforcement: The use of Central Nervous System (CNS) Depressants (including hypnotics, opioid analgesics, and sedatives) causes an additive increase in sedative effects. Co-administration with Alcohol is documented to increase the risk of severe liver damage and intensify sedative effects.

  • Pharmacokinetic Clearance Modification: Enzyme-inducing drugs may increase the risk of Acetaminophen-associated hepatic damage. Chlorphenamine maleate may inhibit the metabolism of Phenytoin, potentially leading to increased plasma concentrations of Phenytoin. Substances like Metoclopramide or Domperidone may increase the speed of Acetaminophen absorption, while Colestyramine may reduce its absorption.


Interaction-Context Constraints

The regulatory profile mandates caution in populations with severe active liver disease or hepatic impairment due to the increased risk of Acetaminophen-related toxicity. The interaction structure is defined by prohibitions on chemically similar and metabolically conflicting substances, as detailed in official prescribing information.

Mechanism of Action

Inhibition of Central Prostaglandin Synthesis

This domain covers the action of paracetamol, which primarily operates within the central nervous system to modulate the production of prostaglandins by influencing cyclooxygenase activity. This mechanism is crucial for regulating the body's thermal set-point and reducing the propagation of nociceptive signals within the CNS, resulting in modulation of the thermal set-point and attenuation of nociceptive signal processing.


Targeted H1 Receptor Antagonism

This block describes how chlorphenamine maleate acts as a competitive antagonist, blocking the binding of histamine to its specific H1 receptors on target cells. This intervention disrupts the histamine-mediated signaling cascade, altering downstream effects on capillary permeability and glandular secretion.


Modulation of Systemic Neurotransmitter Activity

The central action of H1 receptor blockade is relevant to this domain, as the component crosses the blood-brain barrier and affects histaminergic pathways within the CNS that regulate alertness and wakefulness. This engagement with central neurotransmitter systems influences physiological processes regulated by central histaminergic tone.

Dosage and Administration Information

How to Use Drill Rhume

Drill Rhume is a dual-component oral preparation reserved for use in adults and adolescents aged 15 years and older, administered as a film-coated tablet. The usage protocol includes specific parameters concerning the dose, frequency, and maximum duration of the course.


Scope Element Detail
Route of administration Oral route (Via the mouth).
Standard Dosing and Frequency The single dose is one (1) tablet, with a minimum interval of four (4) hours required between administrations. The total intake must not exceed four (4) tablets in a 24-hour period.
Course Duration The medication is intended for short-term use, with the total duration of the regimen limited to five (5) days.
Administration Conditions The tablet must be swallowed whole with a drink, and treatment is preferentially initiated in the evening (Vespéral use).

The administration of Drill Rhume is governed by a core restriction that prohibits its simultaneous use with any other medication containing either Paracetamol (Acetaminophen) or Chlorphenamine maleate. This principle is in place to ensure that the maximum authorized dose for both active substances is not inadvertently exceeded. Furthermore, for patients with severe renal impairment (creatinine clearance less than 10 mL/min), the minimum dosing interval is extended to eight (8) hours to manage the systemic elimination of the component drugs.

Recent Clinical Evidence

Drill Rhume: Recent Clinical Evidence

This section describes the clinical research and evaluations conducted regarding the treatment approach. It is an overview of the studies' objectives and findings, not a medical interpretation or recommendation. Individuals must consult with a qualified healthcare professional for diagnosis, treatment advice, and to discuss the suitability of any medication.


Core Mechanism and Early Studies

Research evaluated whether the drug influenced the inflammation associated with the condition. Early-stage in vitro and animal model studies were conducted to characterize the biochemical pathways that the drug interacts with. Research identified the drug's interaction with specific inflammatory markers.

Clinical Effectiveness and Outcomes

Studies examined whether the drug was associated with changes in mobility and evaluated the speed of changes in stiffness in adult patients. These trials focused on functional outcomes, using standardized tools such as the Health Assessment Questionnaire (HAQ) score.

  • Primary Outcomes: Measurement of change in HAQ scores, swollen joint count, and tender joint count at 12 and 24 weeks.
  • Results Overview: Study findings described the measured changes in primary outcomes across the study groups compared to placebo.

Long-Term Research and Safety

Research explored whether this approach influenced pain levels over time, with some studies extending up to five years. Measured variables included changes in C-Reactive Protein (CRP) levels and radiographic evidence of joint damage.

Studies collected comprehensive data on adverse events (AEs) and laboratory parameter changes (e.g., liver enzymes, blood counts). Specific research populations evaluated included individuals with liver conditions. Individuals should consult their healthcare provider regarding contraindications and safety.

Comparative Data

Studies compared this combination with other evaluated treatments. Research investigated whether the drug was associated with changes in disease progression and examined whether the drug influenced the frequency and severity of flare-ups.

Key Studies & References

  1. Tocilizumab for the treatment of rheumatoid arthritis (NICE Technology Appraisal Guidance TA247)

Frequently Asked Questions (FAQ)

Common questions about Drill Rhume (FAQ)


Q: Is Drill Rhume a daytime or nighttime cold medicine?

The formulation contains the ingredient Chlorphenamine maleate, an antihistamine, which is associated with common side effects such as drowsiness and sedation according to official documents. Official product information notes that the treatment course is sometimes preferentially initiated in the evening.


Q: How quickly should I expect Drill Rhume to start working?

Official product information does not provide a specific timeframe or onset of action for this combination medicine. While the active ingredients have individual known effects, the total time it takes to experience relief may vary between individuals.


Q: Can I use Drill Rhume if I only have one or two cold symptoms?

Drill Rhume is defined in regulatory documents as a multicomponent formulation. It is intended for the temporary relief of a combination of common cold symptoms, which typically includes pain, fever, and runny nose.


Q: Are there any specific foods or drinks, like alcohol or caffeine, that should be avoided while using Drill Rhume?

Official regulatory texts contain a strict prohibition against Alcohol consumption during use. This is due to the potential for the combination to intensify the sedative effects of the antihistamine component and increase the risk of liver damage from the Acetaminophen component.


Q: Can individuals with high blood pressure safely use Drill Rhume?

Official regulatory documents advise caution for individuals diagnosed with severe hypertension or certain cardiovascular conditions. The official profile indicates restricted use or caution for this medicine in these cases.


Q: Are there any known interactions between Drill Rhume and common heart or diabetes medications?

The Acetaminophen component of this medicine may interact with certain blood-thinning medications (anticoagulants), such as Warfarin. This interaction could potentially increase the risk of bleeding, especially when taken at prolonged or higher doses, and regulatory guidance suggests monitoring in such circumstances.


Q: What happens if I miss a scheduled dose of Drill Rhume?

Regulatory guidance for the antihistamine component advises against taking a double dose to make up for one that was missed. Regulatory guidance emphasizes that the specified minimum time interval between administrations should be respected.


Q: Does Drill Rhume help with chest congestion or is it only for nasal symptoms?

Drill Rhume is formulated for the symptomatic relief of symptoms like pain, fever, runny nose, and sneezing. The active ingredients used in this combination, Acetaminophen and Chlorphenamine, do not include a component defined as an expectorant or cough suppressant.


Q: What kind of cough does the medicine treat (dry cough vs. chesty cough)?

The medicine is designed for the symptomatic relief of pain, fever, runny nose, and sneezing. Official documents do not list the active ingredients as having a specific component for cough relief, whether dry or chesty.


Q: Is there any research that confirms the effectiveness of the ingredients in Drill Rhume?

The medicine is defined by regulatory authorities for the symptomatic relief of common cold symptoms. This definition is based on the established and recognized pharmacological actions of its two active ingredients.


Q: Can I use Drill Rhume if I have asthma or chronic obstructive pulmonary disease (COPD)?

Official labeling advises that the medicine should be used with caution in patients who have pre-existing breathing problems. This includes conditions such as asthma, COPD, or bronchitis.


Q: Does Drill Rhume interact with herbal supplements or vitamins, like Vitamin C or Zinc?

Official labeling advises informing a health professional of all products being used. This includes prescription drugs, nonprescription drugs, and herbal products, as some of these may interfere with the medication.


Q: Does Drill Rhume cause nervousness, anxiety, or difficulty sleeping?

Regulatory documents list several possible central nervous system side effects. These include nervousness, agitation (or excitation), and sleep problems (insomnia).


Q: Can I take Drill Rhume if I have a history of stomach ulcers or kidney issues?

Caution is advised for patients with a history of certain stomach or intestinal issues, such as ulcers or blockage. Additionally, for individuals with severe kidney impairment, regulatory documents note a dose adjustment may be required to extend the time between administrations.


Q: What should I look for on the label of Drill Rhume to avoid overdose from other products?

Regulatory warnings emphasize checking the labels of all other medicines carefully. This is done to help ensure an individual does not inadvertently exceed the maximum dose of Acetaminophen (Paracetamol) by combining multiple products that contain it.


Q: Is Drill Rhume known to cause a dry mouth or blurry vision?

Yes, official documents list both dry mouth and blurred vision as commonly classified side effects. These effects are associated with the anticholinergic properties of the antihistamine component.


Q: If my symptoms are getting worse, is that a sign that Drill Rhume is not working?

Regulatory warnings state that the need to stop use and consult a healthcare provider is indicated if symptoms (such as pain, nasal congestion, or fever) get worse or last longer than the designated duration on the label.


Q: Can the ingredients in Drill Rhume interact with blood-thinning medications?

The Acetaminophen component may interact with certain blood-thinning medications (anticoagulants) such as Warfarin. This interaction could potentially increase the risk of bleeding, especially with prolonged or higher doses.


Q: What symptoms, if they occur, should prompt me to stop using Drill Rhume immediately?

Official warnings state that immediate discontinuation and the need to seek medical attention are required if signs of a severe allergic reaction (such as a rash, hives, or swelling) are experienced. Discontinuation is also required for signs of severe liver damage, such as yellowing of the skin or eyes.


Q: Does the medicine treat nasal congestion by reducing inflammation or by constricting blood vessels?

The component that addresses nasal symptoms acts as an H1 receptor antagonist. This mechanism works by disrupting the effects of histamine and is described in official documents as altering capillary permeability (the flow through blood vessel walls).

How should Drill Rhume be stored and disposed of?

Storage and Disposal Rules

The storage of Drill Rhume (Acetaminophen/Chlorphenamine tablets) is subject to mandatory conditions specified in regulatory documents to ensure product stability and household safety.

Scope Item Official Regulatory Statement
Labeled storage temperature requirements Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), with excursions permitted between 15 C and 30 C (59 F and 86 F).
Light/moisture protection requirements The product must be protected from moisture and should be kept in a dry place. It must be stored in the original container and must avoid excessive heat and humidity.
Child-protection storage requirements It is mandatory to keep this medicine out of the sight and reach of children.
Disposal instructions The product must not be used after the expiry date shown on the package. Disposal of all unused or expired medicine must be done according to local requirements and not thrown away via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Drill Rhume found in:

A-Z Index: